Atricure Stock Today
| ATRC Stock | USD 35.74 0.06 0.17% |
Performance14 of 100
| Odds Of DistressLess than 8
|
AtriCure is trading at 35.74 as of the 25th of November 2024, a 0.17 percent increase since the beginning of the trading day. The stock's open price was 35.68. AtriCure has only a 8 % chance of going through financial distress over the next few years and had a good performance during the last 90 days. Note, on August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of AtriCure's common stock.
Business Domain Health Care Equipment & Services | IPO Date 5th of August 2005 | Category Healthcare | Classification Health Care |
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. The company has 48.75 M outstanding shares of which 2.25 M shares are presently shorted by private and institutional investors with about 3.86 trading days to cover. More on AtriCure
Moving together with AtriCure Stock
Moving against AtriCure Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
AtriCure Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Michael Carrel | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAtriCure can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AtriCure's financial leverage. It provides some insight into what part of AtriCure's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AtriCure (ATRC) is traded on NASDAQ Exchange in USA. It is located in 7555 Innovation Way, Mason, OH, United States, 45040 and employs 1,200 people. AtriCure is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.74 B. AtriCure conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 48.75 M outstanding shares of which 2.25 M shares are presently shorted by private and institutional investors with about 3.86 trading days to cover.
AtriCure currently holds about 118.45 M in cash with 4.48 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.55.
Check AtriCure Probability Of Bankruptcy
Ownership AllocationThe majority of AtriCure outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AtriCure to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AtriCure. Please pay attention to any change in the institutional holdings of AtriCure as this could imply that something significant has changed or is about to change at the company. On August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of AtriCure's common stock.
Check AtriCure Ownership Details
AtriCure Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-09-30 | 1.2 M | |
| Ubs Asset Mgmt Americas Inc | 2024-09-30 | 1 M | |
| Gw&k Investment Management, Llc | 2024-09-30 | 1 M | |
| Fmr Inc | 2024-09-30 | 973.5 K | |
| Millennium Management Llc | 2024-06-30 | 952.8 K | |
| Fiera Capital Corporation | 2024-06-30 | 918.2 K | |
| Neuberger Berman Group Llc | 2024-06-30 | 868.4 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 782.9 K | |
| Wasatch Advisors Lp | 2024-09-30 | 769.3 K | |
| Vanguard Group Inc | 2024-09-30 | 4.7 M | |
| Blackrock Inc | 2024-06-30 | 4.6 M |
AtriCure Historical Income Statement
AtriCure Stock Against Markets
AtriCure Corporate Management
| Deborah Yount | Chief Officer | Profile | |
| Valerie StorchWillhaus | Vice Communications | Profile | |
| Tonya SPHR | VP HR | Profile | |
| Vinayak Doraiswamy | Chief Officer | Profile | |
| Amalio MD | Ex Officer | Profile | |
| JD CCEP | Chief Officer | Profile |
Already Invested in AtriCure?
The danger of trading AtriCure is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AtriCure is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AtriCure. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AtriCure is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 9.564 | Quarterly Revenue Growth 0.179 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.